Allergan, Inc.: FDA filings under this applicant name

FDA lists 38 510(k) clearances under 2 spellings of the applicant name “Allergan, Inc.” (first 1982, latest 2021), plus 8 PMA and 1 De Novo decisions, across 20 product codes in 5 review panels. Median 510(k) review time under this name: 75 days. Since 2017 the median was 212 days, against 166 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.

510(k) clearances per year

YearClearancesMedian review days
20120—
20131203
20140—
20151269
20161179
20170—
20182148
20191146
20201252
20211212
20220—
20230—
20240—
20250—
20260—

Review time against the same product codes

Since 2017, 510(k)s cleared under the name Allergan, Inc. took a median 212 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 166 days.

Top product codes

Product codeDeviceSubmissions510(k) clearances
LPNAccessories, Soft Lens Products1212
HPXLens, Contact (Polymethylmethacrylate)88
HQCUnit, Phacofragmentation33
LCJTissue Expander And Accessories33
LMHImplant, Dermal, For Aesthetic Use30
FTRProsthesis, Breast, Noninflatable, Internal, Silicone Gel-Filled20
HNOKeratome, Ac-Powered22
QBRIntranasal Electrostimulation Device For Dry Eye Symptoms21
EIBSyringe, Irrigating (Dental)11
FWMProsthesis, Breast, Inflatable, Internal, Saline10

Plus 10 more product codes.

Review panels

Most recent Allergan, Inc. 510(k) clearances

510(k)DeviceProduct codeDecision dateReview days
K203229NATRELLE INSPIRA Single Use Sizers for Gel ImplantsMRD2021-06-02212
K193589TrueTear Intranasal Tear NeurostimulatorQBR2020-08-31252
K190674REFRESH RELIEVA For CONTACTSLPN2019-08-08146
K180826Natrelle 133 Plus MICROCELL Tissue ExpanderLCJ2018-12-21266
K182054Natrelle 133S Tissue ExpanderLCJ2018-08-2929
K161457XEN Glaucoma Treatment SystemKYF2016-11-21179
K143354Natrelle 133 Plus Tissue ExpanderLCJ2015-08-20269
K123128SERI SURGICAL SCAFFOLDOXF2013-04-25203
K083812REFRESH OPTIVE LENS COMFORT REWETTING DROPSLPN2009-07-09199
K051852SINGLE AMPLIFIER FOR BOTOXGWL2005-09-1468

28 earlier clearances. See the full list in Caduvo.

PMA and De Novo decisions

NumberPathwayDeviceDecision date
DEN170086De NovoIntranasal Electrostimulation Device For Dry Eye Symptoms2018-05-17
P110033PMAJUVEDERM VOLUMA XC2013-10-22
P040046PMANATRELLE HIGHLY COHESIVE SILICONE-FILLED BREAST IMPLANTS2013-02-20
P020056PMANATRELLE SILICONE-FILLED BREAST IMPLANTS2006-11-17
P050047PMAJUVEDERM 24HV, JUVEDERM 30 AND JUVEDERM 30HV GEL IMPLANTS2006-06-02

Recalls

5 product recalls in 4 recall events; 0 initiated in the last five years. Most recent: 2015-06-18.

17 product recalls in 9 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 1 initiated in the last five years. Most often: Allergan PLC (10), Inamed Corp (3), Advanced Medical Optics, Inc. (2).

These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.

Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.

Device clinical trials

An industry sponsor named Allergan, Inc. is the lead sponsor of 67 device studies on ClinicalTrials.gov (1 active or recruiting). Most recent:

Related HCPCS codes

HCPCS Level II codes whose descriptors match the device names of the product codes filed under Allergan, Inc. (a text match, not an official crosswalk):

FDA spellings included

FDA records this applicant under 2 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:

Other FDA applicant names starting with the same word

FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.

Frequently asked questions

How many FDA 510(k) clearances are listed under Allergan, Inc.?

FDA lists 38 510(k) clearances under 2 spellings of the applicant name “Allergan, Inc.” (first 1982, latest 2021), plus 8 PMA and 1 De Novo decisions, across 20 product codes in 5 review panels. Filings under other applicant names, such as subsidiaries, are not included.

How long has FDA taken to clear 510(k)s filed by Allergan, Inc.?

The median time from FDA receipt to decision across 510(k)s cleared under the name Allergan, Inc. is 75 days. Since 2017: 212 days, versus 166 days for all cleared 510(k)s in the same product codes.

Which FDA product codes appear under Allergan, Inc.?

The most frequent FDA product codes under this applicant name are LPN (Accessories, Soft Lens Products, 12); HPX (Lens, Contact (Polymethylmethacrylate), 8); HQC (Unit, Phacofragmentation, 3).

Next steps

Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.

All FDA device companies · FDA product code lookup